Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-05-11 Sale |
2021-05-12 8:38 pm |
TherapeuticsMD Inc. | TXMD | Milligan John C.K. IV Secretary/CEO of subsidiary |
44,252 | $1.04 | $46,022 | 5,542,076 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-05-10 Exercise |
2021-05-12 8:38 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Milligan John C.K. IV Secretary/CEO of subsidiary |
103,500 | $0 | 5,542,076 (Direct) |
View |
2021-03-04 Tax Withholding |
2021-03-08 9:06 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Milligan John C.K. IV President/Secretary |
29,964 | $1.46 | 5,275,828 (Direct) |
View |
2021-03-04 Exercise |
2021-03-08 9:06 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Milligan John C.K. IV President/Secretary |
179,000 | $0.2444 | 5,275,828 (Direct) |
View |
2021-03-04 Exercise |
2021-03-08 9:06 pm |
N/A 2021-03-06 |
TherapeuticsMD Inc. | TXMD | Milligan John C.K. IV President/Secretary |
179,000 | $0 | 5,275,828 (Direct) |
View |
2020-06-05 Gift |
2021-03-08 9:06 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Milligan John C.K. IV President/Secretary |
434,814 | $0 | 5,275,828 (Indirect) |
View |
2020-11-24 Option Award |
2020-11-27 5:05 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Milligan John C.K. IV President/Secretary |
360,000 | $0 | 360,000 (Direct) |
View |